EyePoint Pharmaceuticals
EYPT
#5228
Rank
ยฃ1.10 B
Marketcap
ยฃ13.38
Share price
0.45%
Change (1 day)
92.70%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ0.15 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has ยฃ0.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

EyePoint Pharmaceuticals - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ0.26 B28.27%
2023-12-31$ยฃ0.20 B162.43%
2022-12-31$ยฃ79.65 M-41.68%
2021-12-31$ยฃ0.13 B904.19%
2020-12-31$ยฃ13.6 M114.13%
2019-12-31$ยฃ6.35 M
2018-06-30$ยฃ8.84 M-13.7%
2017-06-30$ยฃ10.25 M-34.56%
2016-06-30$ยฃ15.66 M5.17%
2015-06-30$ยฃ14.89 M70.78%
2014-06-30$ยฃ8.72 M72.24%
2013-06-30$ยฃ5.06 M-41.73%
2012-06-30$ยฃ8.69 M-62.74%
2011-06-30$ยฃ23.32 M7.06%
2010-06-30$ยฃ21.78 M52.5%
2009-06-30$ยฃ14.28 M-5.46%
2008-06-30$ยฃ15.11 M-63.79%
2007-06-30$ยฃ41.73 M-41.29%
2006-06-30$ยฃ71.08 M107.77%
2005-06-30$ยฃ34.21 M133.22%
2004-06-30$ยฃ14.67 M471.49%
2003-06-30$ยฃ2.56 M
2001-06-30$ยฃ3.23 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NRC Health
NRC
ยฃ10.74 M-92.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-ยฃ2.16 Million-101.44% Bahamas